CrestPoint Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-7,165
Closed -$231K 217
2016
Q3
$231K Hold
7,165
0.12% 203
2016
Q2
$221K Hold
7,165
0.12% 196
2016
Q1
$214K Sell
7,165
-1,257
-15% -$34.7K 0.12% 199
2015
Q4
$233K Buy
8,422
+1,257
+18% +$35.8K 0.13% 170
2015
Q3
$219K Sell
7,165
-2,263
-24% -$78.8K 0.13% 177
2015
Q2
$345K Hold
9,428
0.18% 169
2015
Q1
$333K Buy
+9,428
New +$323K 0.17% 171
2014
Q3
Sell
-27,440
Closed -$783K 212
2014
Q2
$783K Sell
27,440
-503
-2% -$14K 0.46% 83
2014
Q1
$799K Sell
27,943
-1,848
-6% -$48.1K 0.5% 74
2013
Q4
$790K Buy
+29,791
New +$829K 0.52% 69

Other funds holding EHC

CrestPoint Capital Management's EHC Position: Q4 2016 in Review

CrestPoint Capital Management sold out of Encompass Health (EHC) in Q4 2016, closing a stake of 7,165 shares — an estimated $231K sold.

CrestPoint Capital Management first reported a position in EHC in Q4 2013 and held it in 10 quarters. The position peaked at $799K in Q1 2014. 321 funds tracked by Wall St. Rank hold EHC as of Q4 2016.

  • CrestPoint Capital Management reported no remaining Encompass Health position as of Q4 2016 after selling out during the quarter.
  • CrestPoint Capital Management sold 7,165 Encompass Health shares in Q4 2016, an estimated $231K.
  • CrestPoint Capital Management first reported a position in Encompass Health in Q4 2013 and held it in 10 quarters.
  • CrestPoint Capital Management's Encompass Health position peaked at $799K in Q1 2014.
  • 321 funds tracked by Wall St. Rank held Encompass Health as of Q4 2016.

Based on CrestPoint Capital Management's 13F filing for Q4 2016, filed 19 Jan 2017.